UK’s non-profit vaccine manufacturing centre sold off before opening

A photo of a grey blocky building with a large glass front under a bright blue skye. The building is surrounded by construction sand, there is a digger standing in front of the building and the top of a crane is poking over the top of the roof.

Source: © Richard Pohle/Pool/AFP/Getty Images

Pharmaceutical firm Catalent buys government-backed facility near Oxford

The US-headquartered pharmaceutical company Catalent has bought Vaccine Manufacturing and Innovation Centre (VMIC) that is under construction in Oxfordshire, UK. The government-supported facility was intended to be the country’s first non-profit vaccine producer. Catalent plans to invest £120 million to finish building the centre, which is expected to employ more than 400 people when it eventually opens.